When comparing MILD and SEVERE COVID-19 patient-recovered exosomes, we found that SARS-CoV-2-S peptides were drastically more enriched in the CD41a+ and CD9+ subpopulations of those recovered from MILD patients (Figure 1H). Here, CD9 is linked to COVID-19.